Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Clinical trial NCT00250211 · COMPLETED
Trial details
- NCT number
- NCT00250211
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2011-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.